Status:
TERMINATED
Evaluating the Effectiveness of a Drug Education and Diversion Program for Middle and High School Students
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Massachusetts Department of Health
Conditions:
Adolescent Behavior
Substance Use
Eligibility:
All Genders
10-22 years
Phase:
NA
Brief Summary
The primary goal of this study is to evaluate the effectiveness of the iDECIDE curriculum as an alternative to punitive responses for school-based substance use infractions.
Detailed Description
The primary goal of this study is to evaluate the effectiveness of the iDECIDE curriculum as an alternative to punitive responses for school-based substance use infractions. To accomplish this aim, in...
Eligibility Criteria
Inclusion
- Eligibility criteria for the primary aim (i.e., evaluating how student-level outcomes change when schools transition from a standard disciplinary response to having access to a more educational and therapeutic alternative):
- Enrolled in a participating middle or high school;
- Received a substance use-related infraction at school or school-sanctioned event;
- Have a parent or legal guardian who is able and willing to provide written informed consent (if under the age of 18);
- Competent and willing to provide written informed consent (if age 18+) or assent (if under 18);
- Able to read and write comfortably in English;
- In the opinion of the investigator, able to safely participate in the protocol.
Exclusion
- Passive consent for referral to MGH evaluation team declined by parent or legal guardian;
- Gross cognitive impairment, for example due to florid psychosis, intellectual disability, developmental delay, or neurodegenerative disease;
- Ward of the state.
- Eligibility criteria for participants for exploratory aims:
- In addition to the students with school-based substance use infractions enrolled for the primary aims, three additional cohorts of participants will be recruited for exploratory aims. The eligibility criteria for these cohorts are listed below.
- Exploratory Aim 1: evaluating the impact of transition from punitive responses for substance use to iDECIDE on overall prevalence of substance use and perceptions of school culture (Annual School-Wide Assessment)
- Inclusion Criteria:
- Currently enrolled in a participating middle or high school;
- Provide informed assent/consent for participation in this research by voluntarily completing the survey.
Key Trial Info
Start Date :
February 4 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 14 2023
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT05321563
Start Date
February 4 2022
End Date
September 14 2023
Last Update
December 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114